You just read:

Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva

News provided by

Clementia Pharmaceuticals, Inc.

Nov 21, 2014, 07:30 ET